Iodeto De Sódio (131i) Ge Healthcare

Sodium Iodide (131I), the active ingredient in Iodeto De Sódio (131i) Ge Healthcare, is a diagnostic radiopharmaceutical presented as an oral preparation for thyroid imaging use. It enables visualization of thyroid function and structure in patients undergoing evaluation for thyroid disorders.

GNH USA supplies Iodeto De Sódio (131i) Ge Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iodeto De Sódio (131i) is employed in diagnostic procedures that assess thyroid function and anatomy. - Thyroid scintigraphy: visualizes functional thyroid tissue to assess hormone production patterns. - Hyperthyroidism evaluation: distinguishes toxic nodular disease from Graves' disease by measuring iodine uptake. - Thyroid cancer staging: detects residual or metastatic thyroid tissue after thyroidectomy. - Ectopic thyroid tissue identification: locates thyroid tissue outside the neck for surgical planning.

Adverse reactions may occur following administration of Iodeto De Sódio (131i).

Common Side Effects: - Nausea: mild to moderate feeling of stomach upset. - Metallic taste: transient alteration of taste perception. - Headache: mild to moderate headache lasting a few hours. - Dry mouth: temporary reduction in salivary flow.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling requiring medical attention. - Radiation thyroiditis: inflammation of the thyroid gland causing pain. - Severe hypothyroidism: marked reduction in thyroid hormone production. - Bone marrow suppression: rare decrease in blood cell counts.

Before using Iodeto De Sódio (131i), consider the following safety measures. - Pregnancy: avoid unless the diagnostic benefit outweighs potential fetal radiation risk. - Breastfeeding: discontinue nursing or choose an alternative, as iodine can be secreted in milk. - Baseline thyroid function: assess thyroid hormone levels prior to administration. - Radiation safety: limit close contact with pregnant persons and young children for 24 hours after dosing. - Renal impairment: evaluate kidney function, as excretion may be delayed. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

Iodeto De Sódio (131i) may interact with other agents that affect iodine metabolism or radiation exposure.

Major Interactions (Avoid): - Concurrent radioactive iodine therapies: may lead to cumulative radiation dose. - Iodinated contrast media: can block thyroid uptake of the radiopharmaceutical. - Antithyroid drugs (e.g., methimazole, propylthiouracil): reduce iodine uptake and compromise imaging quality.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement (levothyroxine): may alter baseline thyroid activity. - Diuretics: can affect renal clearance of iodine. - Iodine‑rich supplements (e.g., kelp, seaweed): may compete with tracer uptake.